2019-10-22 09:44:521970-01-01 00:00:00

Trump Talks Trade with the UK 

On the second day of Trump’s visit in the UK, during which he has been hosted by Queen Elizabeth II and Prime Minister Theresa May, the US president exhibited his ambitions for a “phenomenal” post-Brexit trade deal with the UK. He claimed that transatlantic trade between the two countries could be “two and even three times what we’re doing now” after Brexit, but made it clear that it would involve painful choices for Britain.

Trump appraised the “special relationship” between the two nations. “It’s the greatest alliance the world has ever known,” he told reporters at Britain’s Foreign Office, as the western alliance prepares to mark the 75th anniversary of the landings on D-Day on Thursday.

When talking about the trade deal, the President said Britain’s public health sector should be on the table in future trade talks between the two countries after Brexit; May responded to some areas of the UK economy might be off-limits. “Everything will be on the table; the NHS, everything,” Mr Trump said at a joint conference with UK Prime Minister Theresa May, who also stressed: “The point about making trade deals, of course, is that both sides negotiate and come to an agreement about what should or should not be in that trade deal for the future.”

The National Health Service (NHS) is a publicly funded national healthcare system for many Britons. Created after World War II, it provides a wide range of free services ranging from routine consultations to life-saving operations. In 2017 the US took up 18 percent of UK exports and 11 percent of its imports, while the EU accounted for 45 percent and 53 percent respectively.

Trump demanded plenty of concessions including the NHS be opened up to more American companies, which means the NHS has to pay higher prices for drugs made by American firms. The NHS currently pays significantly less for medicines from American companies than US healthcare purchasers. On top of that, the UK should accept US food products such as hormone-treated beef and chlorine-dipped chicken, both of which are currently banned under EU rules. Mrs May replied the UK would not accept any lowering of food or environmental standards after Brexit.

British Health Minister Matt Hancock, a contender to replace May as Prime Minister, struck back Trump’s proposal on Twitter: “Dear Mr President. The NHS isn’t on the table in trade talks and never will be. Not on my watch.” Other Tory leadership contenders including foreign secretary Jeremy Hunt, the front-runner Boris Johnson and environment secretary Michael Gove also stated that they would not allow to include the NHS in transatlantic trade talks.

During the most time of the meeting, Trump let pass controversial topics such as the Huawei ban and the Iran tension while talked over sensitive issues such as her possible succession. Trump also mentioned Johnson, the former London mayor, who has said that the United Kingdom should leave the EU on October 31, deal or no deal, and Jeremy Hunt, Britain’s foreign minister who has warned against leaving without a deal.

The UK’ position on Huawei

Some friction between the allies has been Britain’s preliminary decision to allow Huawei a restricted role in building parts of its 5G network. Trump has blocked use of Huawei’s 5G equipment in the US and is pressing allies to do likewise. The White House has advised allies not to use Huawei’s 5G technology and equipment for the fears it could allow China to spy on sensitive communications and data through potential hidden back-doors and warned it could impact on intelligence-sharing. But the UK National Security Council (Mrs May is the chair) agreed in April to let Huawei join parts of Britain’s 5G mobile phone networks roll-out.

However, Trump said there should be “no problem” with an intelligence sharing between the US and the UK based on his conversations with May, raising the prospect of a possible climb-down on the safety issues in the intelligence sharing between US and UK. Trump said the two governments are going to have an arrangement on Huawei without any limitations.

“Negative” Jeremy Corbyn

Trump said he had rejected the request from Jeremy Corbyn, the “negative” Labour leader, who pledged to strongly oppose US companies take over the NHS. Trump described him as “somewhat of a negative force”. Jeremy Corbyn is a socialist, who boycotted the banquet held in the President’s honour. During his speech, the politician attracted many protesters to central London on Tuesday. When questioned on this issue, President Trump denied seeing any protests and accused that “a lot of it is fake news.”

By Steven Gao

Click here for a 7 days access to our Lotus Blue Portal.

KOSEC does not take into account the investment objectives, financial situation and advisory needs of any particular person, nor does the information provided constitute investment advice. Under no circumstances should investments be based solely on the information provided. KOSEC is intended to provide general information only. Please be aware that investing involves the risk of capital loss. This message is confidential and may be privileged. It is intended only for the use of the addressee named above. If you are not the intended recipient, any unauthorised dissemination, distribution or copying is illegal. We do not guarantee the security or completeness of information hereby transmitted and are not liable in either respect or in respect of any delay. Nothing in this message is intended as an offer or solicitation for the purchase or sale of any financial instrument. Any market prices or data, unless specifically verified and identified as such, are not warranted as to completeness or accuracy. Kodari Securities Pty Ltd (KOSEC) is a Corporate Authorised Representative (No. 399 556) of Longhou Capital Markets (AFSL No. 292464) which is regulated by the Australian Securities and Investment Commission (ASIC). KOSEC wishes to disclose that KOSEC and its staff may hold stock they recommend in their own portfolios and that any decision to purchase recommended stock should be done so after the purchaser has made their own inquires as to the suitability to their own requirements. Click here to view our FSG.

KOSEC Terms & Conditions

Kodari Securities Pty Ltd (CAR 399556) trading as KOSEC is regulated by the Australian Securities and Investment Commission (ASIC). KOSEC is a financial services company and any information provided by its platforms, portals, reports and documents is protected by copyright. Any unauthorised production of this information is prohibited.
KOSEC reserves the right to change or remove any information provided on our website, reports or any documents including these terms and conditions at any time without notice. The change or modification to the terms and conditions will be effective immediately upon posting an updated version on our website, necessary platforms and documents. It is recommended that you review the information provided on our website, including these terms and conditions frequently for any changes.

Disclaimer
KOSEC provides general advice only. The information provided is of a general nature only and does not take into account your individual objectives, financial situation or needs. It should not be used, relied upon, or treated as a substitute for specific professional advice. KOSEC recommends that you obtain your own independent professional advice before making any decision in relation to your particular requirements or circumstances. Please make sure you read our Financial Services Guide (FSG).

KOSEC does not guarantee any returns. Past performance of any product discussed is not indicative of future performance. (We urge that caution should be exercised in assessing past performance. All financial products are subject to market forces and unpredictable events that may adversely affect their future performance). Investing in the stock market can incur huge losses. Please also be aware that fees will incur on every transaction regardless of the performance of your investments or returns generated. Employees and or associates of KOSEC may hold one or more of the stocks, securities or investments reviewed by the company.

Your use of information from our website, reports, documents and from talking to our representatives/associates is at your risk. Under no circumstance should the investment be based solely on KOSEC information and general advice. You should seek professional financial planning advice.
KOSEC aims to maintain the accuracy of the data and information provided on this website, by using information prepared from a wide variety of sources, which KOSEC to the best of its knowledge and belief, considers accurate and does not make any representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability, suitability or availability of the information provided.

We may at times refer to third parties, which the details of these third parties have been provided solely for you to obtain further information about other relevant products and entities in the market. KOSEC has no control over the information third parties have, or the products or services offered, and therefore make no representations regarding the accuracy or suitability of such information, products or services. You are advised to make your own enquiries in relation to third parties. Our inclusion of any third party content is not an endorsement of that content or the third party.

Fees
As a client you will be charged a yearly service fee and a set brokerage fee per transaction. Your service fee will automatically renew at the end of your agreed 12 month period at the same rate advertised at the time. Your credit card or bank account will be charged for a further year following which will again auto renew until you cancel your yearly service fee. You can cancel the auto renewal at any time in advance of the renewal date by contacting us. KOSEC is aware of the need to ensure the security of your credit card details and our payment systems are compliant with the Payment Card Industry (PCI) Data Security Standard.

Privacy
You consent to receiving email correspondence from KOSEC, as well as companies KOSEC has an association with. These emails will be sent by KOSEC and third party companies. You can opt out of receiving any category of emails at any time by contacting us. We may from time to time inform you of special offers, or even ask your opinion of the services we provide, but your involvement is optional. Should you request us to do so, we will archive your details.

Indemnity and Liability
You indemnify KOSEC from all claims or threatened claims, suits, demands, damages, costs as well as including legal costs incurred in dealing with any threatened claim, expenses made by any person or corporation against KOSEC and any other amounts which is caused by KOSEC providing information, execution and General Advice.

You hold KOSEC harmless and release it from any liability in respect of any loss, harm or damage arising from a decision made by you on the basis of information obtained through the use of our portal, reports, documents or any General Advice given and any transaction taken place.

You hold KOSEC harmless and release it from any liability in respect of any loss, harm or damage arising from delays in executing orders for the client and acknowledges KOSEC makes no guarantees about the time taken to execute an order on behalf of the client. You acknowledge that KOSEC relies on third parties in providing technology and release KOSEC from any harm, loss or damage you may suffer as a result of the failure of such information technology.

Cookies and Links
KOSEC website, and its portal uses cookies, which lets us identify your browser while you are using the site or our portal. Cookies do not identify you personally. They simply allow us to track your usage patterns. If you prefer not to receive cookies, you can configure your browser to reject them or to notify you when they are being used. The functionality of the KOSEC website may be impacted if you restrict the use of cookies.

Fill up the form below and we will get back to you as soon as possible.

CLAIM YOUR FREE E-BOOK &
7 DAY ACCESS TO LOTUS BLUE

STOCK MARKET SUCCESS

KOSEC’s CEO, Michael Kodari’s new book, “Stock Market Success” valued at $39.95, available at Dymocks book stores with all the proceeds going to Dymocks Children’s Charities.

CLAIM YOUR FREE E-BOOK WHEN YOU LOGIN TO LOTUS BLUE INVESTMENT PORTAL

Latest TV Commercial